[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fJAqRoOCrmixz95t2v3YR3ikrBb6wQFOALNzpf3QYU5o":8,"$fTPo5Bla47wUywyN51PjUx0sUuURe3otXoSs5QYxIIks":54,"$fVes6n8bRD4Qd8ZYR5c1A_YDpZOiMt-ZyFor2A2i-osw":58},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":53},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":25,"views":26,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":27,"seoTitle":22,"seoKeywords":28,"seoDescription":29,"shelvesTime":30,"version":31,"menus":32,"menuId":34,"type":41,"quality":52,"commentCount":21,"isComment":41},45949,868773,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//wYq3bZzRAuJu76J8Se2g4h7OcKPVKzRF.png","金厅","浙江省肿瘤医院","放疗科","副主任医师",22,0,"下咽恶性肿瘤相关药品使用指南","","https://ystcdn.venuertc.com/venue/AI/4a485cea-a6a2-4b34-9ed0-670e4f81480e.jpg","\u003Cdiv class=\"drugguide-larynx-container\">\n  \u003Ch2 id=\"material_title\" class=\"drugguide-larynx-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">下咽恶性肿瘤相关药品使用指南\u003C/h2>\n\n  \u003C!-- 简介 -->\n  \u003Cdiv class=\"drugguide-larynx-section drugguide-larynx-intro\">\n    \u003Cdiv class=\"drugguide-larynx-bgheader\">\n      \u003Ch2 class=\"drugguide-larynx-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">安全用药，细节为先 🌿\u003C/h2>\n    \u003C/div>\n    \u003Cp class=\"drugguide-larynx-p\">\n      在下咽恶性肿瘤的治疗中，药品的使用贯穿全过程。无论是化疗药、靶向治疗还是免疫药物，每一步都离不开对安全用药细节的把控。这篇用药指南将针对多西他赛、顺铂、尼妥珠单抗、卡瑞利珠单抗等常见药品，带你深入解读7个关键用药细节，让安全、高效的用药成为每位患者生活的一部分。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 01 用药成分和剂型 -->\n  \u003Cdiv class=\"drugguide-larynx-section\">\n    \u003Cdiv class=\"drugguide-larynx-bgheader\">\n      \u003Ch2 class=\"drugguide-larynx-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01. 常用药品的成分与剂型 🧪\u003C/h2>\n    \u003C/div>\n    \u003Cp class=\"drugguide-larynx-p\">\n      下咽恶性肿瘤治疗中主要用到以下几类药物：\n    \u003C/p>\n    \u003Cul class=\"drugguide-larynx-list\">\n      \u003Cli>\u003Cb>多西他赛（Docetaxel）：\u003C/b>紫杉醇类化疗药，常见为注射液剂型。\u003C/li>\n      \u003Cli>\u003Cb>顺铂（Cisplatin）：\u003C/b>含铂的化疗药，通常为注射液。\u003C/li>\n      \u003Cli>\u003Cb>尼妥珠单抗（Nimotuzumab）：\u003C/b>靶向EGFR的单克隆抗体注射液。\u003C/li>\n      \u003Cli>\u003Cb>卡瑞利珠单抗（Camrelizumab）：\u003C/b>免疫检查点抑制剂，为注射用粉针剂。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"drugguide-larynx-p\">这些药物均采用静脉注射的给药方式，剂型选择和规格需由医生根据个人体表面积计算，不可自行更换。\u003C/p>\n  \u003C/div>\n\n  \u003C!-- 02 药理作用机制 -->\n  \u003Cdiv class=\"drugguide-larynx-section\">\n    \u003Cdiv class=\"drugguide-larynx-bgheader drugguide-larynx-bg1\">\n      \u003Ch2 class=\"drugguide-larynx-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02. 药品作用机制（原理简述）🔬\u003C/h2>\n    \u003C/div>\n    \u003Cp class=\"drugguide-larynx-p\">\n      这些药品在体内起效方式不同，但都对肿瘤细胞有特殊作用：\n    \u003C/p>\n    \u003Cul class=\"drugguide-larynx-list\">\n      \u003Cli>\u003Cb>多西他赛：\u003C/b>影响微管生成，阻止细胞分裂。\u003C/li>\n      \u003Cli>\u003Cb>顺铂：\u003C/b>与DNA结合，影响遗传物质复制，导致细胞死亡。\u003C/li>\n      \u003Cli>\u003Cb>尼妥珠单抗：\u003C/b>靶向结合细胞表面EGFR，抑制肿瘤细胞生长信号通路。\u003C/li>\n      \u003Cli>\u003Cb>卡瑞利珠单抗：\u003C/b>激活T细胞，增强身体自身免疫系统对异常细胞的识别和杀灭。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"drugguide-larynx-p\">作用机制只有在准确用法、合理剂量下才能安全高效发力。\u003C/p>\n  \u003C/div>\n\n  \u003C!-- 03 具体使用方法与细节 -->\n  \u003Cdiv class=\"drugguide-larynx-section\">\n    \u003Cdiv class=\"drugguide-larynx-bgheader drugguide-larynx-bg2\">\n      \u003Ch2 class=\"drugguide-larynx-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03. 正确用药方法与给药细节 🕰️\u003C/h2>\n    \u003C/div>\n    \u003Cul class=\"drugguide-larynx-list\">\n      \u003Cli>\n        \u003Cb>静脉注射是必须：\u003C/b>\n        以上药品只适合静脉滴注，绝不可改为口服或其它途径。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>剂量个体化：\u003C/b>\n        用量需医生根据体表面积、肾功能、肝功能等数据评估，每次治疗前必须核对。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>用药频率：\u003C/b>\n        如多西他赛、顺铂常采用每3周一周期；免疫药（卡瑞利珠单抗）可为2-3周注射一次，具体方案由医生定。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>滴注前准备：\u003C/b>\n        多西他赛易致过敏反应，医生会安排预防性使用激素及抗过敏药。顺铂需大量补液，预防肾毒性。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>用药时监测：\u003C/b>\n        治疗过程中要持续观察体征，发现异常需及时报告医疗人员。静脉通道要定期检查，避免刺激和渗漏。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"drugguide-larynx-p\">\n      \u003Cspan class=\"drugguide-larynx-highlight\">正确做法：\u003C/span>每次药品使用前务必由专业护士及药师复核，严格核实患者身份、药品名称和剂量，注射过程不能擅自离开。\n    \u003C/p>\n    \u003Cdiv class=\"drugguide-larynx-case\">\n      \u003Cb>用药案例：\u003C/b>临床应用多西他赛联合顺铂静脉注射时，多由化疗护士使用专用输注泵严格控制滴速，与医生设定方案保持完全一致。\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 04 药物相互作用专栏 -->\n  \u003Cdiv class=\"drugguide-larynx-section\">\n    \u003Cdiv class=\"drugguide-larynx-bgheader drugguide-larynx-bg3\">\n      \u003Ch2 class=\"drugguide-larynx-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04. 药物相互作用与协同问题 ♻️\u003C/h2>\n    \u003C/div>\n    \u003Cp class=\"drugguide-larynx-p\">\n      这些药品与其它药物合用时，需特别警惕药物间的相互影响：\n    \u003C/p>\n    \u003Cul class=\"drugguide-larynx-list\">\n      \u003Cli>\n        \u003Cb>多西他赛：\u003C/b>与酮康唑、红霉素等CYP3A4抑制剂同用会增强毒性，应避免；与其它化疗药需按医嘱联合用药，避免药物冲突。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>顺铂：\u003C/b>不能与氨基糖苷类抗生素或强利尿药联用，以防肾功能损害加重。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>尼妥珠单抗：\u003C/b>不建议与其它靶向类、强干扰免疫系统药物同时使用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>卡瑞利珠单抗：\u003C/b>部分免疫抑制剂可能影响其疗效，用药前详细告知医生全部药品清单。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"drugguide-larynx-p\">\n      \u003Cspan class=\"drugguide-larynx-highlight\">需要注意：\u003C/span>合用时药物间的协同与冲突风险较高，务必在医生指导下使用，绝不能自行增减药物。\n    \u003C/p>\n    \u003Cdiv class=\"drugguide-larynx-case\">\n      \u003Cb>用药案例：\u003C/b>有位患者因自行接受他药治疗，导致与多西他赛产生不良反应，后调整用药顺序后症状缓解。\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 05 用药禁忌和特殊人群 -->\n  \u003Cdiv class=\"drugguide-larynx-section\">\n    \u003Cdiv class=\"drugguide-larynx-bgheader drugguide-larynx-bg4\">\n      \u003Ch2 class=\"drugguide-larynx-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05. 禁忌症与特殊人群用药 👪\u003C/h2>\n    \u003C/div>\n    \u003Cul class=\"drugguide-larynx-list\">\n      \u003Cli>\n        \u003Cb>多西他赛：\u003C/b>对多西他赛或制剂辅料过敏者禁用；肝功能严重异常时不可使用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>顺铂：\u003C/b>孕妇、哺乳期禁用，听力障碍、严重肾功能损伤者慎用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>尼妥珠单抗：\u003C/b>有严重过敏反应史者禁用；妊娠及哺乳期风险不明，需权衡利弊。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>卡瑞利珠单抗：\u003C/b>自身免疫性疾病者慎用；有活动性感染者禁用。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"drugguide-larynx-p\">老年或肝肾功能不全患者，应提前调整剂量，并加强监测。\u003C/p>\n    \u003Cdiv class=\"drugguide-larynx-tip\">\n      \u003Cspan class=\"drugguide-larynx-highlight\">特别提醒：\u003C/span>用药前请如实提供个人病史及目前使用的所有药物清单。\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 06 常见不良反应和处理 -->\n  \u003Cdiv class=\"drugguide-larynx-section\">\n    \u003Cdiv class=\"drugguide-larynx-bgheader drugguide-larynx-bg5\">\n      \u003Ch2 class=\"drugguide-larynx-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06. 不良反应及处理要点 🚨\u003C/h2>\n    \u003C/div>\n    \u003Cul class=\"drugguide-larynx-list\">\n      \u003Cli>\n        \u003Cb>多西他赛：\u003C/b>最常见为白细胞减少、脱发、过敏反应。给药前预防、用药期间严密筛查，发生异常及时处理。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>顺铂：\u003C/b>可能出现肾功能损伤、恶心呕吐和耳鸣。充分补液、对症处理、监测肾功能是关键。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>尼妥珠单抗：\u003C/b>偶见皮疹、注射部位反应，需要对症护理。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>卡瑞利珠单抗：\u003C/b>免疫相关不良反应如皮疹、肝酶升高等，定期抽血监测，异常及时报告医生。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"drugguide-larynx-p\">数据提示：多西他赛诱导白细胞减少的发生率＞70%，大多数可逆。\u003Cbr>\n      \u003Cspan class=\"drugguide-larynx-highlight\">正确做法：\u003C/span>出现持续水肿、呼吸不适、尿量减少等症状时应立刻告知医生，避免自行停药或自行服药。\n    \u003C/p>\n    \u003Cdiv class=\"drugguide-larynx-case\">\n      \u003Cb>用药案例：\u003C/b>患者接受顺铂治疗期间，一度出现轻度耳鸣，及时减量处理后未见明显进展。\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 07 储存条件及药品有效期 -->\n  \u003Cdiv class=\"drugguide-larynx-section\">\n    \u003Cdiv class=\"drugguide-larynx-bgheader drugguide-larynx-bg6\">\n      \u003Ch2 class=\"drugguide-larynx-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07. 药品储存和保存要求 🗃️\u003C/h2>\n    \u003C/div>\n    \u003Cul class=\"drugguide-larynx-list\">\n      \u003Cli>\n        \u003Cb>多西他赛、顺铂注射液：\u003C/b>需存放在2-8℃冰箱冷藏，避免冷冻，阳光直射。开封后需在规定时间内一次用完。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>尼妥珠单抗、卡瑞利珠单抗：\u003C/b>冻干粉应避光保存于2-8℃，配制后需4小时内静脉滴注完成。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>过期药品：\u003C/b>过期或变色药液禁止注射，需按医院规范处理，不能自行丢弃或继续使用。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"drugguide-larynx-p\">\n      \u003Cspan class=\"drugguide-larynx-highlight\">必要措施：\u003C/span>家庭储存药物时慎防误食、小孩触碰，确保药品不随意转交他人。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 08 漏服与过量处理 -->\n  \u003Cdiv class=\"drugguide-larynx-section\">\n    \u003Cdiv class=\"drugguide-larynx-bgheader drugguide-larynx-bg7\">\n      \u003Ch2 class=\"drugguide-larynx-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08. 漏服与过量怎么办？⏳\u003C/h2>\n    \u003C/div>\n    \u003Cul class=\"drugguide-larynx-list\">\n      \u003Cli>\n        \u003Cb>滴注药品：\u003C/b>如漏服或漏注一周期，切忌自行补用，务必联系主治医生，重新调整治疗计划。\u003C/li>\n      \u003Cli>\n        \u003Cb>不慎过量：\u003C/b>立即告知医生或就近送急诊，部分化疗药不存在特效解毒药，处理以支持、对症与监测为主。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>自我处理绝不可取：\u003C/b>自行加频率或调剂量极易引发严重不良反应，危及生命。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"drugguide-larynx-p\">发现用药异常，第一时间与主管医生沟通，不要延误。\u003C/p>\n  \u003C/div>\n\n  \u003C!-- 09 常见疑问专项解答 -->\n  \u003Cdiv class=\"drugguide-larynx-section\">\n    \u003Cdiv class=\"drugguide-larynx-bgheader drugguide-larynx-bg8\">\n      \u003Ch2 class=\"drugguide-larynx-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09. 用药实践中常见疑问解答 💡\u003C/h2>\n    \u003C/div>\n    \u003Cul class=\"drugguide-larynx-list\">\n      \u003Cli>\n        \u003Cb>化疗药瓶如果摇晃起泡还有用吗？\u003C/b>\n        严禁用力摇晃药液，一旦出现明显气泡或沉淀，建议废弃，并通知专业人员处理。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>用药间期可以自行调整吗？\u003C/b>\n        不可自行更改用药时间表，提前或推迟都有失疗效和安全保证。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>出现轻微皮疹后怎么办？\u003C/b>\n        不要自行停药或用药，及时报告医生，听取具体管理建议。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>注射部位肿胀怎么办？\u003C/b>\n        出现局部红肿、疼痛立即停药，报告护士，避免药液外渗进一步刺激局部组织。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\n  \u003C!-- 10 结语及总体建议 -->\n  \u003Cdiv class=\"drugguide-larynx-section drugguide-larynx-summary\">\n    \u003Cdiv class=\"drugguide-larynx-bgheader drugguide-larynx-bg9\">\n      \u003Ch2 class=\"drugguide-larynx-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">总结：用药安全底线不可松懈 🎯\u003C/h2>\n    \u003C/div>\n    \u003Cp class=\"drugguide-larynx-p\">\n      不论是哪类药品，按医嘱精确剂量、按时静脉滴注、遇特殊情况随时沟通，这三步是用药安全最重要的底线。化疗、靶向与免疫治疗各有不同风险，每一步都容不得马虎。日常生活中，严格执行药品储存、遵循专业操作及密切观察异常反应，是保护自己和家人健康的关键。如果遇到不懂的问题，主动向医生、药师咨询，不讳言、不拖延，才能让治疗效果更加稳妥。\n    \u003C/p>\n    \u003Cp class=\"drugguide-larynx-p\">\n      \u003Cb>告诉身边每一位用药者：\u003C/b>安全用药不是口号，是需要落实到每一次输液、每一个细节中的责任与守护。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 英文文献引用 -->\n  \u003Cdiv class=\"drugguide-larynx-section drugguide-larynx-ref\">\n    \u003Cdiv class=\"drugguide-larynx-bgheader drugguide-larynx-bgref\">\n      \u003Ch2 class=\"drugguide-larynx-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003C/div>\n    \u003Col class=\"drugguide-larynx-ref-list\">\n      \u003Cli>Ferrari, D., et al. (2012). \"Docetaxel in head and neck cancer: a review of the literature.\" \u003Ci>Critical Reviews in Oncology/Hematology\u003C/i>, 83(1), 23-36.\u003C/li>\n      \u003Cli>Hedley, D. W., et al. (2016). \"Cisplatin: mode of cytotoxic action and molecular basis of resistance.\" \u003Ci>Oncogene\u003C/i>, 25, 4094-4106.\u003C/li>\n      \u003Cli>García-Foncillas, J., et al. (2018). \"Immunotherapy with checkpoint inhibitors in head and neck cancer: rationale and clinical evidence.\" \u003Ci>Frontiers in Oncology\u003C/i>, 8, 310.\u003C/li>\n      \u003Cli>UpToDate. \"Systemic therapy for non-nasopharyngeal head and neck cancers,\" updated 2023. (https://www.uptodate.com/contents/systemic-therapy-non-nasopharyngeal-head-neck-cancers)\u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.drugguide-larynx-container {\n  font-family: \"PingFang SC\", \"Microsoft YaHei\", Arial, sans-serif;\n  background: #f9fafb;\n  margin: 0;\n  padding: 24px 10% 36px 10%;\n  max-width: 900px;\n  box-sizing: border-box;\n}\n.drugguide-larynx-title {\n  font-size: 32px;\n  text-align: center;\n  color: #2f4858;\n  margin: 24px 0 30px 0;\n  font-weight: bold;\n  letter-spacing: 1px;\n}\n.drugguide-larynx-section {\n  margin-bottom: 38px;\n  border-radius: 10px;\n  box-shadow: 0 2px 6px #edf1f7;\n  background: #ffffff;\n  padding: 0 0 16px 0;\n  transition: box-shadow 0.3s;\n}\n.drugguide-larynx-section:hover {\n  box-shadow: 0 4px 18px #d8e0ea;\n}\n.drugguide-larynx-bgheader {\n  border-top-left-radius: 10px;\n  border-top-right-radius: 10px;\n  padding: 24px 32px 12px 32px;\n  background: linear-gradient(96deg, #dbefff 0%, #f6faff 90%);\n  border-bottom: 1px solid #e4e8ef;\n  min-height: 52px;\n}\n.drugguide-larynx-h2 {\n  margin: 0;\n  font-size: 24px;\n  color: #214463;\n  font-weight: 500;\n  letter-spacing: 0.5px;\n}\n.drugguide-larynx-bg1 { background: linear-gradient(90deg, #eaf6fb 0%, #f7fbfc 85%);}\n.drugguide-larynx-bg2 { background: linear-gradient(120deg, #fae6f2 0%, #f9fafb 90%);}\n.drugguide-larynx-bg3 { background: linear-gradient(96deg, #fef6e0 0%, #f6f9fa 100%);}\n.drugguide-larynx-bg4 { background: linear-gradient(95deg, #e6f7fa 0%, #f8fafb 90%);}\n.drugguide-larynx-bg5 { background: linear-gradient(90deg, #f9e9ee 0%, #fafbfc 85%);}\n.drugguide-larynx-bg6 { background: linear-gradient(105deg, #f3fbe7 0%, #f8fafb 95%);}\n.drugguide-larynx-bg7 { background: linear-gradient(94deg, #e6f2fb 0%, #f9fafb 100%);}\n.drugguide-larynx-bg8 { background: linear-gradient(95deg, #fff7e9 0%, #f6fafd 90%);}\n.drugguide-larynx-bg9 { background: linear-gradient(91deg, #e8f5e0 0%, #f9fafb 90%);}\n.drugguide-larynx-bgref {\n  background: linear-gradient(90deg, #e4eafc 0%, #f9fafb 100%);\n  padding: 18px 32px 8px 32px;\n}\n\n.drugguide-larynx-p {\n  font-size: 18px;\n  color: #333948;\n  line-height: 1.72;\n  margin: 25px 32px 8px 32px;\n  word-break: break-all;\n}\n.drugguide-larynx-list {\n  margin: 0 40px 10px 62px;\n  padding-left: 0;\n}\n.drugguide-larynx-list li {\n  margin-bottom: 10px;\n  font-size: 17px;\n  color: #305070;\n  line-height: 1.68;\n  padding-left: 6px;\n  position: relative;\n}\n.drugguide-larynx-list li::before {\n  content: \"•\";\n  color: #9c6fbc;\n  display: inline-block;\n  width: 1.5em;\n  margin-left: -1.5em;\n  font-size: 15px;\n}\n.drugguide-larynx-highlight {\n  color: #e26749;\n  font-weight: 600;\n}\n.drugguide-larynx-tip {\n  margin: 11px 32px 6px 32px;\n  font-size: 17px;\n  background: #fff2e1;\n  color: #a54445;\n  border-left: 5px solid #ffc38c;\n  border-radius: 5px;\n  padding: 9px 17px;\n  line-height: 1.6;\n}\n.drugguide-larynx-case {\n  margin: 13px 35px 8px 36px;\n  font-size: 16px;\n  background: #eef7f3;\n  color: #458480;\n  border-left: 4px solid #8bc0bd;\n  border-radius: 3px;\n  padding: 8px 14px;\n  line-height: 1.5;\n}\n.drugguide-larynx-summary {\n  margin-bottom: 36px;\n  border-bottom: 3px solid #b7dedb;\n}\n.drugguide-larynx-ref {\n  background: #fafcff;\n  border-radius: 9px;\n  box-shadow: none;\n  padding-bottom: 8px;\n}\n.drugguide-larynx-ref-list {\n  margin: 18px 40px 0 70px;\n  font-size: 15px;\n  color: #727485;\n  line-height: 1.7;\n  padding-bottom: 8px;\n}\n@media (max-width: 750px) {\n  .drugguide-larynx-container { padding: 10px 3% 22px 3%; }\n  .drugguide-larynx-title { font-size: 24px; }\n  .drugguide-larynx-h2 { font-size: 18px; }\n  .drugguide-larynx-p,.drugguide-larynx-list li { font-size: 15px; }\n  .drugguide-larynx-case,.drugguide-larynx-tip { font-size: 14px; }\n  .drugguide-larynx-ref-list { font-size: 13px; }\n}\n\u003C/style>\n",538,"2025-07-02 17:19:20","下咽恶性肿瘤, 多西他赛, 顺铂, 用药指南, 药物不良反应, 靶向治疗, 免疫治, 化疗","了解下咽恶性肿瘤常用药物的安全使用方法和注意事项，保障用药安全和有效。掌握多西他赛、顺铂等药物的治疗详情和不良反应处理。适合患者及其家属阅读。","2025-07-03 16:56:00",2,[33],{"menuId":34,"menuName":35,"parentId":21,"orderNum":31,"path":36,"component":37,"isFrame":38,"isCache":39,"menuType":40,"visible":41,"status":21,"createDept":6,"remark":23,"createTime":42,"children":43,"columnImage":44,"columnLogo":45,"uncheckedLogo":6,"checkedLogo":6,"isHot":41,"isHome":21,"forceLogin":21,"color":46,"seoTitle":47,"seoKeywords":48,"seoDescription":49,"contentNum":6,"promotionalPoster":50,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":51,"routerPath":36,"componentInfo":37},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":55,"success":53},{"pageNo":41,"pageSize":56,"result":57,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":59,"success":53},{"authors":60,"appraiseDimensionScoresVos":61},[],[]]